# ONCOTHERAPY SOLUTIONS, LLC: Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer.

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ONCOTHERAPY SOLUTIONS, LLC |
| Location | Seattle, WA |
| Project | Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer. |
| Project number | 1R43CA306418-01A1 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $400,000 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-17 to 2027-09-14 |
| UEI | SBJCRLLF26A8 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11402095). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.